Global CRISPR And CRISPR-Associated (Cas) Genes Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Publisher : GlobalInfo Research Publication Date : Dec 27, 2017

Number of Pages : 115 Subcategory : Biotechnology
Single User $ 3480
Global User $ 4680

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.

    Scope of the Report:
    This report focuses on the CRISPR And CRISPR-Associated (Cas) Genes in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    Caribou Biosciences
    Addgene
    CRISPR THERAPEUTICS
    Merck KGaA
    Mirus Bio LLC
    Editas Medicine
    Takara Bio USA
    Thermo Fisher Scientific
    Horizon Discovery Group
    Intellia Therapeutics
    GE Healthcare Dharmacon

    Market Segment by Regions, regional analysis covers
    North America (USA, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Columbia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers

    Market Segment by Applications, can be divided into

    There are 15 Chapters to deeply display the global CRISPR And CRISPR-Associated (Cas) Genes market.

    Chapter 1, to describe CRISPR And CRISPR-Associated (Cas) Genes Introduction, product scope, market overview, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the top manufacturers of CRISPR And CRISPR-Associated (Cas) Genes, with sales, revenue, and price of CRISPR And CRISPR-Associated (Cas) Genes, in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4, to show the global market by regions, with sales, revenue and market share of CRISPR And CRISPR-Associated (Cas) Genes, for each region, from 2012 to 2017;

    Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

    Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

    Chapter 12, CRISPR And CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

    Chapter 13, 14 and 15, to describe CRISPR And CRISPR-Associated (Cas) Genes sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

  • Table of Content

    Global CRISPR And CRISPR-Associated (Cas) Genes Market by Manufacturers, Countries, Type and Application, Forecast to 2022

    Table of Contents

    1 Market Overview
    1.1 CRISPR And CRISPR-Associated (Cas) Genes Introduction
    1.2 Market Analysis by Type
    1.3 Market Analysis by Applications
    1.4 Market Analysis by Regions
    1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
    1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
    1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
    1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
    1.5.1 Market Opportunities
    1.5.2 Market Risk
    1.5.3 Market Driving Force
    2 Manufacturers Profiles
    2.1 Caribou Biosciences
    2.1.1 Business Overview
    2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.1.2.1 Type 1
    2.1.2.2 Type 2
    2.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Addgene
    2.2.1 Business Overview
    2.2.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.2.2.1 Type 1
    2.2.2.2 Type 2
    2.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 CRISPR THERAPEUTICS
    2.3.1 Business Overview
    2.3.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.3.2.1 Type 1
    2.3.2.2 Type 2
    2.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Merck KGaA
    2.4.1 Business Overview
    2.4.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.4.2.1 Type 1
    2.4.2.2 Type 2
    2.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Mirus Bio LLC
    2.5.1 Business Overview
    2.5.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.5.2.1 Type 1
    2.5.2.2 Type 2
    2.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Editas Medicine
    2.6.1 Business Overview
    2.6.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.6.2.1 Type 1
    2.6.2.2 Type 2
    2.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Takara Bio USA
    2.7.1 Business Overview
    2.7.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.7.2.1 Type 1
    2.7.2.2 Type 2
    2.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Thermo Fisher Scientific
    2.8.1 Business Overview
    2.8.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.8.2.1 Type 1
    2.8.2.2 Type 2
    2.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Horizon Discovery Group
    2.9.1 Business Overview
    2.9.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.9.2.1 Type 1
    2.9.2.2 Type 2
    2.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Intellia Therapeutics
    2.10.1 Business Overview
    2.10.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.10.2.1 Type 1
    2.10.2.2 Type 2
    2.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 GE Healthcare Dharmacon
    2.11.1 Business Overview
    2.11.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
    2.11.2.1 Type 1
    2.11.2.2 Type 2
    2.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Competition, by Manufacturer
    3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Manufacturer
    3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Manufacturer
    3.3 Market Concentration Rate
    3.3.1 Top 3 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share
    3.3.2 Top 6 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share
    3.4 Market Competition Trend
    4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Regions
    4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Regions
    4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Regions (2012-2017)
    4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Regions (2012-2017)
    4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    4.4 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    4.5 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    4.6 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    5 North America CRISPR And CRISPR-Associated (Cas) Genes by Countries
    5.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
    5.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
    5.1.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
    5.2 USA CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    5.3 Canada CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    5.4 Mexico CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    6 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries
    6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
    6.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
    6.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
    6.2 Germany CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    6.3 UK CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    6.4 France CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    6.5 Russia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    6.6 Italy CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    7 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes by Countries
    7.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
    7.1.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
    7.1.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
    7.2 China CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    7.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    7.4 Korea CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    7.5 India CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    7.6 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    8 South America CRISPR And CRISPR-Associated (Cas) Genes by Countries
    8.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
    8.1.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
    8.1.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
    8.2 Brazil CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    8.3 Argentina CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    8.4 Columbia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    9 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries
    9.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
    9.1.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
    9.1.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
    9.2 Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    9.3 UAE CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    9.4 Egypt CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    9.5 Nigeria CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    9.6 South Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
    10 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Type
    10.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2012-2017)
    10.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Type (2012-2017)
    10.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2012-2017)
    11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Application
    11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2012-2017)
    12 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
    12.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2017-2022)
    12.2 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Regions (2017-2022)
    12.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
    12.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
    12.2.3 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
    12.2.4 South America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
    12.2.5 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
    12.3 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Type (2017-2022)
    12.4 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Application (2017-2022)
    13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
    13.1.1 Direct Marketing
    13.1.2 Indirect Marketing
    13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
    14 Research Findings and Conclusion
    15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.

Related Products
$2800 - $5500
Publisher : XYZResearch Publication Date : May 21, 2018

Number of Pages : 100 Subcategory : Biotechnology
$2800 - $5500
Publisher : XYZResearch Publication Date : May 21, 2018

Number of Pages : 107 Subcategory : Biotechnology
$2800 - $5500
Publisher : XYZResearch Publication Date : May 21, 2018

Number of Pages : 118 Subcategory : Biotechnology